Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1550 CAD | +3.33% |
|
0.00% | +19.23% |
| Market Cap | 58.44M 41.85M 36.15M 33.31M 31.18M 3.98B 59.34M 393M 153M 1.94B 157M 154M 6.7B | P/E Ratio 2026 * |
-4.83x | P/E Ratio 2027 * | -3.63x |
|---|---|---|---|---|---|
| Enterprise Value | 58.44M 41.85M 36.15M 33.31M 31.18M 3.98B 59.34M 393M 153M 1.94B 157M 154M 6.7B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11.7x |
| Free-Float |
86.83% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +3.33% | ||
| Current month | +10.71% | ||
| 1 month | -3.12% | ||
| 3 months | -8.82% | ||
| 6 months | +14.81% | ||
| Current year | +19.23% |
| 1 week | 0.15 |  | 0.16 |
| 1 month | 0.14 | | 0.17 |
| Current year | 0.12 | | 0.2 |
| 1 year | 0.12 | | 0.21 |
| 3 years | 0.12 | | 1.1 |
| 5 years | 0.12 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 12/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 11/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 11/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tanya Lewis
BRD | Director/Board Member | 55 | - |
John Brooks
CHM | Chairman | 75 | 23/09/2025 |
James Parsons
BRD | Director/Board Member | 60 | 19/04/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-22 | Option | Chairman | 228,912 | 0.0658% | ||
| 05-22 | Option | Director | 166,482 | 0.0479% | ||
| 05-22 | Option | Director | 260,000 | 0.0748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.33% | 0.00% | -6.06% | -82.18% | 41.73M | |
| +2.15% | +3.65% | -18.07% | +11.25% | 117B | |
| -0.31% | +0.04% | +1.12% | -5.11% | 12.86B | |
| +2.05% | +4.21% | +27.90% | +88.29% | 7.29B | |
| +1.87% | -3.51% | -46.74% | -69.06% | 4.12B | |
| +2.06% | +5.59% | +11.04% | +33.01% | 2.49B | |
| +5.46% | +10.30% | -16.96% | -14.78% | 1.7B | |
| +1.67% | -6.39% | +3.63% | -11.43% | 1.63B | |
| -8.89% | -8.45% | +165.17% | +112.14% | 1.49B | |
| Average | +1.06% | +1.32% | +13.45% | +6.90% | 16.53B | |
| Weighted average by Cap. | +1.86% | +1.39% | -12.38% | +12.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.58M 3.09M 2.85M 2.67M 340M 5.08M 33.66M 13.12M 166M 13.44M 13.15M 574M |
| Net income | -12.83M -9.19M -7.93M -7.31M -6.84M -873M -13.03M -86.34M -33.66M -425M -34.48M -33.75M -1.47B | -19.77M -14.16M -12.23M -11.27M -10.55M -1.35B -20.08M -133M -51.89M -655M -53.15M -52.02M -2.27B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 0.1450 $ | -6.45% | 129,330 |
| 11/06/26 | 0.1550 $ | +3.33% | 207,625 |
| 10/06/26 | 0.1500 $ | 0.00% | 6,300 |
| 09/06/26 | 0.1500 $ | 0.00% | 46,335 |
| 08/06/26 | 0.1500 $ | 0.00% | 49,500 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1550CAD
Average target price
0.4500CAD
Spread / Average Target
+190.32%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
